Literature cited
A. K. Aren, Ya. Ya. Ozol, I. A. Abolinya, et al., Khim.-Farmats. Zh., No. 6, 9 (1967).
I. A. Berzinya, S. K. Germane, Ya. Ya. Dregeris, et al., Khim.-Farmats. Zh., No. 10, 25 (1968).
A. K. Aren, I. A. Berzinya, L. S. Geita, et al., Khim.-Farmats. Zh., No. 12, 6 (1970).
A. Kh. Zitsmanis, I. É. Liepinya, and A. K. Aren, Izv. Akad. Nauk Latviisk. SSR, Ser. Khim., No. 3, 309 (1970).
A. Kh. Zitsmanis and A. K. Aren, Izv. Akad. Nauk Latviisk. SSR, Ser. Khim., No. 3, 304 (1970).
A. K. Aren, A. Kh. Zitsmanis, S. K. Germane, et al., Khim.-Farmats. Zh., No. 8, 18 (1968).
A. K. Aren, I. É. Liepinya, and A. Kh. Zitsmanis, Izv. Akad. Nauk Latviisk. SSR, Ser. Khim., No. 4, 439 (1969).
N. W. Dunham and T. S. Miya, J. Am. Pharm. Ass. Sci. Ed.,46, 208 (1957).
J. R. Boissier, Encephale,50, 340 (1961).
N. B. Eddy and D. Leimbach, J. Pharmacol. Exp. Ther.,98, 385 (1953).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 7, No. 11, pp. 16–20, November, 1973.
Rights and permissions
About this article
Cite this article
Berzinya, I.A., Germane, S.K., Ozolin'sh, Y.V. et al. 2-[δ-(N-arylpiperazino)butynyl]- and 2-[δ-(N-arylpiperazino)butyl]-2-phenylindane-1,3-diones. Pharm Chem J 7, 691–694 (1973). https://doi.org/10.1007/BF00757935
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00757935